Source: Imaging Tech; Editor: Jacky
Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.
On November 30, 2023, a global leading medical technology companyBD Medical(New York Stock Exchange code: BDX) announced the launch of a brand-new ultrasound system:SiteRite™ 9 Ultrasound System,Aimed at improving the efficiency of vascular access devices.
#BD MedicalLaunch SiteRite™ 9 Ultrasound System
SiteRite™ 9 Ultrasound System is an all-in-one system featuring an updated 15.6-inch touchscreen for a user-friendly experience, with enhanced image quality and industry-leading catheter placement tools and technology to support clinicians during vascular access device insertion.The system includes integrated visualization tools, such as the Cue™ Needle Tracking System, which provides caregivers with continuous, real-time needle position tracking, and the Sherlock 3CG+™ Tip Confirmation System, which ensures the precise location and positioning of a catheter or needle through imaging technology after placement.
▲Figure:
SiteRite™ 9 Ultrasound System
Eric Borin, Global President of the company's Pharmaceutical Systems business, said: "Our latest innovations in ultrasound technology are designed to allow clinicians to deliver vascular access care more easily and efficiently, enabling both experienced and novice practitioners to master the skills quickly."The company developed this solution to ensure that doctors succeed on the first attempt of catheter or needle insertion, reduce repeated punctures, achieve rapid insertion, and provide patients with a better care experience.”
The SiteRite™ 9 system also incorporates intelligent connectivity technologies, such as vascular assessment tools that automatically detect blood vessels and can be paired with vascular measurement tools to assist clinicians in selecting the appropriate catheter, enabling informed decisions every time. Other system features include patient data lookup, auto-population, and record transfer through information capture to optimize clinical workflow.As a global leader in vascular access solutions, BD is committed to raising the standard of care. This innovative product is part of the company’s vascular access management portfolio and will help clinicians place vascular access devices, ensure successful insertion on the first attempt, and reduce unnecessary needle sticks.SiteRite™ 9 System Received FDA 510(k) Clearance in September and Is Now Available to U.S. Customers.
# Ultrasound System Focused on Vascular Access
The SiteRite™ ultrasound system has been redesigned for vascular access, featuring an expanded screen size, enhanced image quality, and optimized probe connectivity, resulting in the SiteRite™ 9 Ultrasound System. This system is specifically designed for the placement of vascular access devices and serves as the only integrated catheter insertion solution compatible with the market-leading Sherlock 3CG+™ Tip Confirmation System (TCS) and catheter tip tracking and navigation.- Specifically Designed for Vascular Access
SiteRite™ 9 Ultrasound System integrates the Sherlock 3CG+™ Tip Confirmation System (TCS), specifically designed for vascular access. Its visualization tools assist physicians in identifying and measuring blood vessels during PICC procedures.
▲Image source: official website (same below)
With its optimized interface and 15.6-inch touch display (50% larger than SiteRite™ 8), it provides users with an excellent experience.
- Support Equipment Selection
This ultrasound system combines clear visualization of the vascular system with real-time measurements, assisting clinicians in selecting the most appropriate vascular access device. The system automatically detects blood vessels and then applies measurement tools to provide clinicians with information on the catheter-to-vein ratio, complying with the current INS standards for catheter-to-vein ratio guidelines.
- Needle Trajectory Visualization
Cue™ Needle Tracking Technology is used to provide visual feedback on the needle trajectory and tip position relative to the target structure. Compared with "blind" catheter placement, real-time visualization has been shown to help reduce the number of insertion attempts by physicians, thereby improving the patient's ultrasound-guided needle insertion experience.
BD Medical (NYSE:BDX) was founded in 1897,Headquartered in New Jersey, USA. The company produces and sells includingMedical consumables, laboratory instruments, antibodies, reagents, diagnostic products, etc.In 2022, BD's global revenue was $18.869 billion (approximately $137.8 billion). In 2023, BD ranked in the top 20 on the Global Top 100 Medical Device Companies list published by the medical device industry website Medical Design & Outsourcing.In the first half of fiscal 2023, BD's total revenue was $9.407 billion (approximately 65.7 billion yuan), a year-on-year decrease of 0.6%.The three major businesses of BD Medical are the Medical Segment, Life SciencesLearning and Intervention Departments. In the first half of fiscal year 2023, these three businesses accounted for 48%, 27%, and 25% of total revenue respectively. Among them, the medical department increased by 5.6% year-on-year; the life sciences sector was significantly impacted by the sharp decline in demand for COVID-19 testing.A decrease of 13.2% year-over-year; All sectors under the intervention department, including surgical operations, peripheral interventions, urology, and intensive care, maintained growth.An increase of 4.0% year-over-year。
International Medical Imaging Enterprises:Chinese Medical Imaging Companies:
Editor-in-Chief | Zhao Qing Reviewed by | Yi He
